CD44 and osteosarcoma: To examine whether repression of CD44 levels by miR-199a-3p would increase drug sensitivity of osteosarcoma cells, the MTT assay was performed on our previously established cell lines U-2OS/null and U-2OS/miR-199a-3p after incubating with doxorubicin.